ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 883

Evaluation of Fracture Risk and Osteoporosis in Males with Rheumatoid Arthritis

Kanchana Herath1, Melissa Saul2, Lei Zhu3 and Larry W. Moreland3, 1Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 2Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 3Division of Rheumatology and Clinical Immunology, Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Osteoporosis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: 3S086 ACR Abstract: RA–DX, Manifestations, & Outcomes I: Other Co-Morbidities (880–885)

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Osteoporosis is an asymptomatic disease complicated by fractures and is associated with increased morbidity and mortality. Rheumatoid arthritis (RA) has been found to be a secondary cause for osteoporosis and it occurs more frequently in the RA population compared to the healthy population. There is a generalized consensus concerning osteoporosis screening in women, however, no such consensus exists for men due to insufficient available data. Current recommendations are to screen men ages 50-69 with increased risk and all men >70. However, with limited data available on appropriate screening guidelines, many with increased risk of osteoporosis are not being screened.

Objectives: The aims of this retrospective study were to asses if dual-energy x-ray absorptiometry (DEXA) scans are being obtain for males between the ages of 50-69, if these patients have decreased bone mineralization and if there is an increased risk of fractures in male patients with RA between the ages of 50-69.

Methods: A total of 1,970 male RA patients ages 50-69 were identified who were seen in an outpatient setting between the years of 2010-2017. Outpatient clinic notes, DEXA scans, radiology reports, laboratory results for rheumatoid factor (RF) and anti-cyclic citrullinated peptide (CCP), along with hospital medical record discharge abstracts for all patients were retrieved. Outcomes included DEXA scan results and frequency of fractures.

Results: 488 DEXA scan results were obtained with osteopenia reported in 231 patients and osteoporosis reported in 67 patients. Of the overall results, 61% had decreased bone mineralization. Serologies for RF and CCP were compared with DEXA scan results and fractures. Osteoporosis was seen significantly more in the RF positive group compared to the RF negative group (30 and 9 respectively, chi- square 0.0076). Osteoporosis was also seen significantly more in the CCP positive group compared to the negative group (18 and 7 respectively, chi- square 0.027).

Conclusion: Our preliminary data show that in men <70 years of age there is evidence of osteopenia and osteoporosis on DEXA scans, especially in those who are RF and CCP positive. DEXA scans are not being utilized enough in males with RA <70 years of age. Increased screening can help recognize those with decreased bone mineralization who may need treatment to help prevent future fractures.


Disclosure: K. Herath, None; M. Saul, None; L. Zhu, None; L. W. Moreland, None.

To cite this abstract in AMA style:

Herath K, Saul M, Zhu L, Moreland LW. Evaluation of Fracture Risk and Osteoporosis in Males with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/evaluation-of-fracture-risk-and-osteoporosis-in-males-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-fracture-risk-and-osteoporosis-in-males-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology